• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴拉圭原发性和继发性登革热的临床表现及其与病毒血清型的关系。

Clinical manifestations of primary and secondary dengue in Paraguay and its relation to virus serotype.

作者信息

Lovera Dolores, Martínez-Cuellar Celia, Galeano Fernando, Amarilla Sara, Vazquez Cynthia, Arbo Antonio

机构信息

Department of Pediatrics, Institute of Tropical Medicine, Asuncion, Paraguay.

Central Laboratory of Public Health, Asuncion, Paraguay.

出版信息

J Infect Dev Ctries. 2019 Dec 31;13(12):1127-1134. doi: 10.3855/jidc.11584.

DOI:10.3855/jidc.11584
PMID:32088700
Abstract

INTRODUCTION

Dengue virus (DENV) infection is currently a major cause of morbidity in the world, and its incidence has mainly increased during the last years in Latin America, including Paraguay. The objective of this study was to compare the clinical and laboratory findings of dengue and assess whether the serotype is a risk factor for severity.

METHODOLOGY

We included patients ≤ 15 years old hospitalized with dengue at the Institute of Tropical Medicine, from Paraguay, from 2007 to 2018. Patients were classified according to the 2009 WHO dengue classification guidelines and were stratified by serotype into three groups according to the hospitalization period: the 2007 epidemic (DENV-3), the 2012-2013 epidemic (DENV-2) and the 2016-2018 epidemic (DENV-1).

RESULTS

Of 784 children hospitalized for dengue, 50 cases (6.3%) were caused by DENV-3, 471 (60%) by DENV-2, and 263 (33.5%) by DENV-1. Myalgias and headache were associated with DENV-3 cases and abdominal pain was associated with DENV-2 cases. Bleeding was observed mainly in DENV-1 and 2 cases. Patients with DENV-2 infections experienced more severe disease, required fluid expansion more frequently, and exhibited more often shock and admission in the ICU. Secondary cases of dengue were more severe that primary cases. Patients with infection by DENV-2 had longer hospital stays (5.1 ± 2.8 days) when compared to DENV-3 o DENV-1 infection cases (2.9 ± 1.6 days and 4.36 ± 2.7 days, respectively) (p < 0.05).

CONCLUSIONS

The DENV serotype has a profound impact on the clinical manifestations and severity of dengue. DENV-2 infections were associated more frequently to requirement of fluid expansion, shock, and longer hospital stay.

摘要

引言

登革病毒(DENV)感染目前是全球发病的主要原因,在过去几年中,其发病率在包括巴拉圭在内的拉丁美洲主要呈上升趋势。本研究的目的是比较登革热的临床和实验室检查结果,并评估血清型是否为严重程度的危险因素。

方法

我们纳入了2007年至2018年在巴拉圭热带医学研究所住院的15岁及以下登革热患者。患者根据2009年世界卫生组织登革热分类指南进行分类,并根据血清型按住院时间分为三组:2007年疫情(DENV-3)、2012 - 2013年疫情(DENV-2)和2016 - 2018年疫情(DENV-1)。

结果

在784名因登革热住院的儿童中,50例(6.3%)由DENV-3引起,471例(60%)由DENV-2引起,263例(33.5%)由DENV-1引起。肌痛和头痛与DENV-3病例相关,腹痛与DENV-2病例相关。出血主要在DENV-1和2病例中观察到。DENV-2感染患者病情更严重,更频繁地需要液体复苏,且更常出现休克和入住重症监护病房。登革热二代病例比一代病例更严重。与DENV-3或DENV-1感染病例(分别为2.9±1.6天和4.36±2.7天)相比,DENV-2感染患者住院时间更长(5.1±2.8天)(p<0.05)。

结论

DENV血清型对登革热的临床表现和严重程度有深远影响。DENV-2感染更频繁地与液体复苏需求、休克和更长住院时间相关。

相似文献

1
Clinical manifestations of primary and secondary dengue in Paraguay and its relation to virus serotype.巴拉圭原发性和继发性登革热的临床表现及其与病毒血清型的关系。
J Infect Dev Ctries. 2019 Dec 31;13(12):1127-1134. doi: 10.3855/jidc.11584.
2
Episodes of the epidemiological factors correlated with prevailing viral infections with dengue virus and molecular characterization of serotype-specific dengue virus circulation in eastern India.与登革热病毒相关的流行病毒感染的流行病学因素以及印度东部血清型特异性登革热病毒循环的分子特征。
Infect Genet Evol. 2018 Mar;58:40-49. doi: 10.1016/j.meegid.2017.12.005. Epub 2017 Dec 13.
3
Dengue-specific serotype related to clinical severity during the 2012/2013 epidemic in centre of Brazil.巴西中部2012/2013年登革热疫情期间与临床严重程度相关的登革热特定血清型。
Infect Dis Poverty. 2017 Aug 2;6(1):116. doi: 10.1186/s40249-017-0328-9.
4
Changing pattern of dengue virus serotypes circulating during 2008-2012 and reappearance of dengue serotype 3 may cause outbreak in Kolkata, India.2008-2012 年期间循环的登革热病毒血清型发生变化,登革热血清型 3 重现,可能导致印度加尔各答暴发疫情。
J Med Virol. 2016 Oct;88(10):1697-702. doi: 10.1002/jmv.24529. Epub 2016 Mar 29.
5
Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype.以1型登革病毒为主要血清型的2013年缅甸登革热疫情特征分析
Infect Genet Evol. 2016 Sep;43:31-7. doi: 10.1016/j.meegid.2016.04.025. Epub 2016 May 4.
6
Revisiting the dengue epidemic of 2011 in Paraguay: molecular epidemiology of dengue virus in the Asuncion metropolitan area.重新审视 2011 年巴拉圭登革热疫情:亚松森大都市区登革热病毒的分子流行病学。
BMC Infect Dis. 2021 Aug 7;21(1):769. doi: 10.1186/s12879-021-06487-9.
7
Meta-Analysis of Dengue Severity during Infection by Different Dengue Virus Serotypes in Primary and Secondary Infections.初次感染和二次感染中不同登革病毒血清型感染期间登革热严重程度的Meta分析
PLoS One. 2016 May 23;11(5):e0154760. doi: 10.1371/journal.pone.0154760. eCollection 2016.
8
Correlation of serotype-specific dengue virus infection with clinical manifestations.血清型特异性登革病毒感染与临床表现的相关性。
PLoS Negl Trop Dis. 2012;6(5):e1638. doi: 10.1371/journal.pntd.0001638. Epub 2012 May 1.
9
Impact of dengue virus (DENV) co-infection on clinical manifestations, disease severity and laboratory parameters.登革病毒(DENV)合并感染对临床表现、疾病严重程度及实验室指标的影响。
BMC Infect Dis. 2016 Aug 11;16(1):406. doi: 10.1186/s12879-016-1731-8.
10
Serotype-specific differences in the laboratory parameters among hospitalized children with dengue and genetic diversity of dengue viruses circulating in Tamil Nadu, India during 2017.2017 年印度泰米尔纳德邦住院登革热患儿的实验室参数与登革病毒流行株的血清型特异性差异。
J Med Virol. 2020 Aug;92(8):1013-1022. doi: 10.1002/jmv.25639. Epub 2019 Dec 9.

引用本文的文献

1
Global Circulation Dynamics and Its Determinants of Dengue Virus: A Network Evolution and Model Study from 1990 to 2019.登革病毒的全球传播动力学及其决定因素:1990年至2019年的网络演化与模型研究
Viruses. 2025 Aug 4;17(8):1078. doi: 10.3390/v17081078.
2
Epidemiology of dengue fever in Somaliland: clinical features, and serological patterns from a retrospective study.索马里兰登革热的流行病学:一项回顾性研究的临床特征和血清学模式
BMC Infect Dis. 2025 Feb 5;25(1):179. doi: 10.1186/s12879-025-10558-6.
3
Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua.
尼加拉瓜19年儿科临床研究中按血清型和免疫状态划分的登革热严重程度
PLoS Negl Trop Dis. 2025 Jan 10;19(1):e0012811. doi: 10.1371/journal.pntd.0012811. eCollection 2025 Jan.
4
Trends in emerging vector-borne viral infections and their outcome in children over two decades.二十多年来新发的虫媒病毒感染及其儿童结局的趋势。
Pediatr Res. 2024 Jan;95(2):464-479. doi: 10.1038/s41390-023-02866-x. Epub 2023 Oct 25.
5
Comparative Analysis of Human Hepatic Lesions in Dengue, Yellow Fever, and Chikungunya: Revisiting Histopathological Changes in the Light of Modern Knowledge of Cell Pathology.登革热、黄热病和基孔肯雅热患者肝脏病变的比较分析:基于现代细胞病理学知识重新审视组织病理学变化
Pathogens. 2023 May 4;12(5):680. doi: 10.3390/pathogens12050680.
6
Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue.就诊时的血清生物标志物和抗黄病毒抗体可作为重症登革热的指标。
PLoS Negl Trop Dis. 2023 Feb 27;17(2):e0010750. doi: 10.1371/journal.pntd.0010750. eCollection 2023 Feb.
7
Dengue, chikungunya, and Zika virus infections in Latin America and the Caribbean: a systematic review.拉丁美洲和加勒比地区的登革热、基孔肯雅热和寨卡病毒感染:一项系统综述
Rev Panam Salud Publica. 2023 Feb 10;47:e34. doi: 10.26633/RPSP.2023.34. eCollection 2023.
8
Relationship between clinical and laboratory features with infecting dengue virus serotypes in a sample of dengue suspected adult patients from 2015-2017 in Sri Lanka.2015年至2017年斯里兰卡登革热疑似成年患者样本中临床及实验室特征与感染登革热病毒血清型之间的关系
J Clin Virol Plus. 2022 Nov;2(4):None. doi: 10.1016/j.jcvp.2022.100112.
9
Solving Patient Allocation Problem during an Epidemic Dengue Fever Outbreak by Mathematical Modelling.通过数学建模解决登革热疫情期间的患者分配问题
Healthcare (Basel). 2022 Jan 15;10(1):163. doi: 10.3390/healthcare10010163.
10
Use of intravenous N-acetylcysteine in acute severe hepatitis due to severe dengue infection: a case series.静脉注射 N-乙酰半胱氨酸治疗重症登革热感染所致急性重型肝炎:病例系列研究。
BMC Infect Dis. 2021 Sep 20;21(1):978. doi: 10.1186/s12879-021-06681-9.